Skip to main content
. 2019 Nov 1;10(6):557–566. doi: 10.32598/BCN.9.10.385

Figure 1.

Figure 1.

A. Apigenin treatment ameliorated spatial working memory impairment following intracerebroventricular injection of Amyloid-Beta (Aβ) in the Y maze task. The arm entry alterations decreased in the Aβ group (P<0.001 compared with the control group). However, apigenin treatment significantly ameliorated the working memory impairment in the Aβ group (P<0.01 Aβ vs. Aβ+apigenin), n=8.

B. The total number of arm entries in the Y maze test through 8 min. No difference in motor activity was observed in groups (n=8), suggesting the normal activity of animals in all groups.